0
New
New
2022
Left Atrial Appendage (laa) Closure Device Market

Left Atrial Appendage (LAA) Closure Device Market

by Product (Endocardial LAA Devices, Epicardial LAA Devices), by End Use (Hospitals, Ambulatory Surgery Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A03358
Pages: 318
Sep 2022 | 8229 Views
Author(s) : Neha M , Vitika V
Tables: 116
Charts: 51
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

Left Atrial Appendage (LAA) Closure Device Market Research, 2031

The global left atrial appendage closure device market size was valued at $1.3 billion in 2021 and is projected to reach $8.2 billion by 2031, growing at a CAGR of 21% from 2022 to 2031. One of the most common arrhythmias is atrial fibrillation (AF), which affects most of the population worldwide. AF is associated with significant morbidity and mortality, including stroke, heart failure, and death. The most feared complication of AF is a thromboembolic episode that causes a cerebrovascular accident (CVA). There are two primary methods of preventing stroke in patients with AF, namely, oral anticoagulation (AC) therapy, and left atrial appendage (LAA) occlusion or removal. LAA devices are implanted in the heart and are intended to reduce the risk of thromboembolism from the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation. The device mechanically occludes the LAA to prevent LAA thrombus from entering the systemic circulation.

The usage of left atrial appendage closure devices has decreased as a result of the difficulty in executing non-urgent structural heart operations such as left atrial appendage closure procedures due to ICU bed and anaesthesia shortages.

Left Atrial Appendage (LAA) Closure Device Market, LAA Closure Device Market, Left Atrial Appendage Closure Device Market size, Left Atrial Appendage Closure Device Market share, Left Atrial Appendage Closure Device Market trends, Left Atrial Appendage Closure Device Market growth, LAA Closure Device Market analysis, LAA Closure Device Market forecast, LAA Closure Device Market opportunity

Left atrial appendage closure (LAA closure or LAAC) is a minimally invasive medical technique used to significantly lower the risk of stroke in a patient who has atrial fibrillation (also known as Afib or AF) and for whom other methods of treatment have been unsuccessful.

The left atrial appendage (LAA) is a microscopic ear-shaped sac located in the upper left chamber of the heart. During atrial fibrillation, this sac controls the electrical impulses. Left atrial appendage (LAA) closure devices are interventional devices intended to prevent stroke and emboli from atrial fibrillation. Factors such as an increase in the number of atrial intervention product approvals, an increase in the rates of atrial fibrillation and heart stroke cases, an aging population, hypertension-related diseases, and disrupted lifestyle behaviors such as smoking fuel market expansion. Furthermore, increased awareness initiatives in untapped markets give a wealth of chances for market growth throughout the forecast period. These factors are anticipated to propel the left atrial appendage closure device market growth.

However, the availability of substitutes and the high cost of left atrial appendage atrial closure devices may restrict the market growth. Oral anticoagulation is the conventional alternative to left atrial appendage closure devices, and it is strongly advised in persons with non-valvular atrial fibrillation. The development of non-vitamin K oral anticoagulants (NOACs) such as rivaroxaban, dabigatran, apixaban, and edoxaban has made the use of oral anticoagulants among individuals at risk of thromboembolic events simpler. These considerations may have a negative influence on the growth of the market for left atrial appendage (LAA) closure devices. The factors are projected to increase the LAA closure device market opportunity over the forecast period. 

The increasing safety of left atrial appendage (LAA) closure devices is highlighted by many emerging as well as established organizations. Furthermore, the significantly growing adoption of cutting-edge technologies in the left atrial appendage closure device market share is projected to generate higher revenue over the forecast period. Over the last decade, LAA closure has suffered a rapid evolution, as clinical expertise increased along with implant effectiveness and procedural safety significantly improved, which resulted in a rapid increase in the left atrial appendage (LAA) device market size of LAA closure devices. Percutaneous occlusion is a relatively novel and evolving approach that is majorly recommended for patients suffering from atrial fibrillation and increased risk of stroke.

The key players profiled in LAA closure device industry report include Boston Scientific Corporation, Abbott, Lifetech Scientific, ATRICURE, INC., SentreHEART, Inc., Medical Device Business Services, Inc., Occlutech, Cardia, Inc., Johnson & Johnson Private Limited, and Lepu Medical Technology Co., Ltd.

The global left atrial appendage (LAA) closure device market is segmented on the basis of product, end-use, and region. By product, the market is sub-segmented into endocardial LAA devices and epicardial LAA devices. By end-use, the market is classified into hospitals, ambulatory surgery centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The left atrial appendage (LAA) closure device market is segmented into Product and End Use.

Left Atrial Appendage (LAA) Closure Device Market
By Product

Your browser does not support the canvas element.

Endocardial LAA devices sub-sgement held the highest market share in 2021 and is anticiapted to continues it dominace over the forecast period.

Get more information on this report : Request Sample Pages

By product, the endocardial LAA devices sub-segment dominated the market in 2021. the endocardial LAA devices used in patients featured lower complications, shorter hospital stays, and fewer 30-day readmissions. Endocardial LAA devices have been shown in numerous clinical studies to be safer and more effective in managing stroke and reducing bleeding. The market share for left atrial appendage closure devices has been further increased by a robust product pipeline of endocardial LAA devices, including the Watchman device, which has received U.S. approval, and seven other devices that have received the CE mark in Europe and are currently undergoing clinical trials.

Left Atrial Appendage (LAA) Closure Device Market
By End Use

Your browser does not support the canvas element.

Hospitals end use segment is projected to grow at a fastest CAGR over the projected timeframe

Get more information on this report : Request Sample Pages

By end-use, the hospitals sub-segment dominated the global left atrial appendage (LAA) closure device market share in 2021. Owing to a growing preference for left atrial appendage (LAA) procedures and an increase in hospital acceptance of left atrial appendage closure devices the availability of advanced medical technologies, certified medical professionals, and the growing adoption of the latest left atrial appendage closure devices are expected to fuel hospital preference.

Left Atrial Appendage (LAA) Closure Device Market
By Region

2031
North America 
Europe
Asia-pacific
Lamea

North America is anticipated to dominate the global market in the near future

Get more information on this report : Request Sample Pages

By region, North America dominated the global market in 2021 and is projected to remain the fastest-growing sub-segment during the forecast period. Because of several factors, including widespread acceptance of advanced left atrial appendage closure devices, an increase in the incidence of atrial fibrillation, and a well-developed healthcare infrastructure throughout the country. High preference and acceptance of advanced technology in the country, further spurs the left atrial appendage closure devices market growth during the forecast timeframe.

Impact of COVID-19 on the Global Left Atrial Appendage (LAA) Closure Device Market.

  • The COVID-19 outbreak was an unprecedented health crisis that had a significant impact on the market for left atrial appendage closure devices market share.
  • The coronavirus pandemic resulted in the cancellation or postponement of non-urgent procedures, including structural heart (SH) interventional surgeries, in order to reduce unnecessary patient exposure to COVID-19 and preserve ICU capacity for severe SARS-CoV-2 patients.
  • The limitations in ICU beds and anaesthesiology pose a significant barrier to performing non-urgent structural heart interventions such as left atrial appendage closure procedures and reducing the use of left atrial appendage closure devices.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the LAA closure device market forecast segments, current trends, estimations, and dynamics of the left atrial appendage closure device market analysis from 2021 to 2031 to identify the prevailing left atrial appendage closure device market opportunities.
  • Market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • An in-depth analysis of the left atrial appendage closure device market segmentation assists to determine the prevailing market opportunities.
  • Left atrial appendage closure device market trends, major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the LAA closure device market analysis of the regional as well as global left atrial appendage closure device market trends, key players, market segments, application areas, and market growth strategies.

Left Atrial Appendage (LAA) Closure Device Market Report Highlights

Aspects Details
Product
  • Endocardial LAA Devices
  • Epicardial LAA Devices
End Use
  • Hospitals
  • Ambulatory Surgery Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, United Kingdom, France, Spain, Italy, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest Of Asia Pacific)
  • LAMEA  (Brazil, Saudi Arabia, UAE, South Africa, Rest of LAMEA)
Key Market Players sentreheart, inc., Boston Scientific Corporation, AtriCure, Inc., Abbott Laboratories, Occlutech, lifetech scientific corporation, Cardia, Inc., Aegis Medical Group., Biosense Webster, Inc., Johnson & Johnson Services, Inc.
 

Loading Table Of Content...


 
 

The rise in prevalence of atrial fibrillation (AF), which affects most of the population worldwide is anticipated to propel the demand for left atrial appendage (LAA) closure devices in the near future. Preventing stroke in patients with AF demand for left atrial appendage (LAA) closure device is the key factor that is projected to drive the growth of the global left atrial appendage (LAA) closure device market size during the forecast period. In addition, the aging population will increase the atrial fibrillation disease burden, as the elderly are more susceptible to arrhythmia, ischemic stroke disease and atrial fibrillation. However, left atrial appendage (LAA) devices are expensive and susceptible to rupture due to their instability. The main factors anticipated to restrain market expansion during the projected period are the overall cost of the devices is rising as a result of sustained technical improvement and the incorporation of advanced technology. On the contrary, rapid growth of the medical industry and rise in extensive use of endocardial procedures in atrial fibrillation in the previous years are anticipated to provide remunerative opportunities for key players in the upcoming years.

Among the analyzed regions, North-America is expected to account for the highest revenue in the market by the end of 2031, followed by Asia-Pacific, Europe, and LAMEA. Increase in prevalence of atrial fibrillation (AF) urbanization and technological advancements in medical sector are the key factors responsible for leading position of Asia-Pacific and North-America in the global left atrial appendage (LAA) closure device market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The population will increase the atrial fibrillation disease burden, as well as Left atrial appendage closure can benefit people who need heart surgery and also have atrial fibrillation. In addition, rise in the extensive use of endocardial procedures in atrial fibrillation in the previous years is anticipated to provide remunerative opportunities for key players in the upcoming years. Is estimated to generate excellent opportunities in the left atrial appendage (LAA) closure device market.

A. Atrial fibrillation is a heart disease that is associated with a fivefold increase in the risk of stroke as well as rising morbidity and mortality. Left atrial appendage closure devices are a promising site-direct therapy for stroke prevention in patients. Such applications are expected to drive the adoption of the left atrial appendage (LAA) closure device in the market.

A. Left atrial appendage (LAA) closure device is used to prevent Cardioembolic stroke which is a major cause of morbidity and mortality in patients with atrial fibrillation (AF). Also, it acts as a replacement for oral anticoagulants, because some people can’t tolerate these medications. After all, it leads to a risk of bleeding. Such applications of the device are anticipated to boost the left atrial appendage (LAA) closure device market in the upcoming years.

A. Hospitals sub-segment of the end-use industry acquired the maximum share of the global left atrial appendage (LAA) closure device market in 2021.

A. Asia-Pacific will provide more business opportunities for the global Left Atrial Appendage (LAA) Closure Device market in future.

A. Boston Scientific Corporation, Abbott, Lifetech Scientific, ATRICURE, INC., SentreHEART, Inc., Medical Device Business Services, Inc., Occlutech, Cardia, Inc., Johnson & Johnson Private Limited, and Lepu Medical Technology Co., Ltd. Are the major players in the left atrial appendage (LAA) closure device market.

A. The major growth strategies adopted by left atrial appendage (LAA) closure device market players are investment and collaboration.

A. The report provides an extensive qualitative and quantitative analysis of the current trends and future estimations of the global left atrial appendage (LAA) closure device market from 2021 to 2031 to determine the prevailing opportunities.

A. Medical industry leaders are the major customer in the global left atrial appendage (LAA) closure device market.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Left Atrial Appendage (laa) Closure Device Market

Start reading instantly.
This Report and over 19,300+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Sep 2023 - Sep 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2023 - Sep 2024)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2023 - Sep 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2023 - Sep 2024)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2023 - Sep 2024)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers